| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1d80b3db2d5f2d4a75992d6f137c03c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9647f41b85d79320d26eb6ae4b44bbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cebdb44f18c382ac446b3e93b3e5463 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-23 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2000-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9766c3d5c34e388fd23827ad33b8e49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d51456769b97ae43ca132be45fb62195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5c3aae0f394ed671fe449dbf3718d0b |
| publicationDate |
2004-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1152767-B1 |
| titleOfInvention |
Method for producing anti-tumor th1 cells |
| abstract |
The invention relates to a pharmaceutical preparation comprising tumor-reactive cells similar to Th1 which produce large quantities of interferon gamma and produce little or no interleukin 4; together with pharmaceutically compatible excipients and auxiliary agents. The invention also relates to a method for producing tumor-reactive cells similar to Th1 which produce large quantities of interferon gamma and produce little or no interleukin 4. |
| priorityDate |
1999-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |